IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - EUGMP Certification From National Institute Of Pharmacy And Nutrition, Hungary
With reference to the Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we are pleased to inform that National Institute of Pharmacy and Nutrition, Hungary has issued 'Certificate of GMP Compliance of Manufacturer' for Company's products. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation under Regulation 39 (3) of Securities and Exchange Board of India (Listing Obligations and Disclosure Requirements) Regulations, 2015 IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018
Please find enclosed herewith a certificate received from M/s. Alankit Assignment Limited, Registrar and Share Transfer Agent of the Company in compliance with the requirements of Regulation 74(5) of SEBI (Depositories and Participants) Regulations, 2018 for the quarter ended 31st December 2022. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Closure of Trading Window
Pursuant to the requirements of SEBI (Prohibition of Insider Trading) Regulations, 2015 and Company's 'Code of Conduct to Regulate, Monitor and Reporting of Trading by Designated Persons' the Trading Window for dealing in the securities of the Company, shall remain closed for all the designated persons and their immediate relatives from 1st January 2023 till the expiry of 48 hours after the declaration of financial results for quarter and nine months ended 31st December 2022 are made public. During the closure of Trading Window, Insiders are also advised not to deal in the shares of the Company. The date of the Board Meeting at which the financial results would be approved will be informed in due course. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Newspaper Publication
Copy of Notice published in newspapers regarding loss of Share Certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Increase In Volume
With reference to your mail, reference no.: L/SURV/ONL/PV/SR/2022-2023/369 dated 22nd December 2022, we wish to submit that there is no such announcement or price sensitive information, which is pending to be intimated by the Company to the Stock Exchange that have a bearing on the operation /performance of the Company. We would like to further inform and clarify that all the information furnished by the Company is in public domain and Company will keep the Stock Exchanges duly informed of all the price sensitive information(s) in compliance with SEBI (Listing Obligations and Disclosures Requirements) Regulations, 2015. We trust this will clarify your queries. IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Compliances-Reg. 39 (3) - Details of Loss of Certificate / Duplicate Certificate
Intimation of lost share certificates IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
Virtual Call with Analyst/Institutional Investors IOL CHEMICALS & PHARMACEUTICALS LTD. - 524164 - Intimation Of Granting Of Patent
Dear Sir, With reference to captioned subject and Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that Controller of Patent, Indian Patent Office; Government of India has granted Patent for invention entitled AN IMPROVED SAFE PROCESS FOR THE PREPARATION OF SARTAN DRUGS OF FORMULA I. Valsartan, Losartan, Irbesartan, Olmesartan, Candesartan and other Sartan drugs are a class of medicines known as angiotensin II receptor blocker (ARBs) used to treat high blood pressure and heart failure.